Related Experiment Video
Updated: Oct 5, 2025
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges
Behrouz Shademan1, Sepideh Masjedi2, Vahidreza Karamad1
1Department of Medical Biology, Faculty of Medicine, EGE University, Izmir, Turkey.
Abstract:
A novel gene editing tool, the Cas system, associated with the CRISPR system, is emerging as a potential method for genome modification. This simple method, based on the adaptive immune defense system of prokaryotes, has been developed and used in human cancer research. These technologies have tremendous therapeutic potential, especially in gene therapy, where a patient-specific mutation is genetically corrected to cure diseases that cannot be cured with conventional treatments. However, translating CRISPR/Cas9 into the clinic will be challenging, as we still need to improve the efficiency, specificity, and application of the technology. In this review, we will explain how CRISPR-Cas9 technology can treat cancer at the molecular level, focusing on ordination and the epigenome. We will also focus on the promise and shortcomings of this system to ensure its application in the treatment and prevention of cancer.
Insights
The CRISPR-Cas9 gene editing tool offers potential for cancer therapy by correcting mutations. Further research is needed to improve its efficiency and specificity for clinical application in cancer treatment.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- CRISPR-Cas9 is a novel gene editing tool derived from prokaryotic adaptive immunity.
- It has been applied in human cancer research, showing therapeutic potential for genetic diseases.
Purpose of the Study:
- To review CRISPR-Cas9's molecular mechanisms for treating cancer.
- To focus on its application in cancer treatment and prevention, addressing both promise and limitations.
Main Methods:
- Review of CRISPR-Cas9 technology.
- Focus on molecular-level cancer treatment strategies.
- Examination of epigenetic modifications and gene regulation.
Main Results:
- CRISPR-Cas9 technology can modify the genome for therapeutic purposes.
- The system has potential in gene therapy for curing genetic diseases, including cancer.
- Challenges remain in improving efficiency, specificity, and clinical application.
Conclusions:
- CRISPR-Cas9 holds significant promise for cancer therapy and prevention.
- Further development is crucial to overcome current limitations for effective clinical translation.
- Understanding its impact on the epigenome is key to its successful application.
More Related Videos
Related Concept Videos
01:59CRISPR
01:28CRISPR/Cas9 Genome Editing
02:53CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
02:31Homologous Recombination
00:49What is Genetic Engineering?